中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 3
Mar.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(3): 708-713

Association between cholesterol and liver regeneration and its significance and potential value in clinical treatment of liver failure

DOI: 10.3969/j.issn.1001-5256.2022.03.044
  • 1.

    Graduate School of Guangxi University of Chinese Medicine, Nanning 530200, China

  • 2.

    Second Ward of Hepatology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China

  • 3.

    Guangxi University of Chinese Medicine, Nanning 530000, China

Research funding:

National Natural Science Foundation of China (81704021);

National Natural Science Foundation of China (81760844);

National Natural Science Foundation of China (8170150729);

National Major Science Technology Project (2018ZX10725505-001-011);

Guangxi Science and Technology Plan Project (2020GXNSFAA297098);

Postgraduate Innovation Project of Guangxi University of Chinese Medicine (YCXJ2021034)

More Information
  • Corresponding author: YAO Chun, 1197840425@qq.com(ORCID: 0000-0002-6612-874X)
  • Received Date: 2021-07-13
  • Accepted Date: 2021-08-13
  • Published Date: 2022-03-20
    Abstract
  • Liver failure is a common severe liver disease syndrome in clinical practice and is one of the critical medical conditions in internal medicine. Massive hepatocyte death is the main pathological feature of liver failure, and its core mechanisms include endotoxin, immune response, and inflammatory cascade reaction. Effective regeneration of hepatocytes to compensate liver function is the physiological basis for promoting the good prognosis of liver failure, which directly affects the prognosis and quality of life of patients with liver failure. It has been found in clinical practice that liver failure patients with a low serum level of cholesterol tend to have an extremely high mortality rate, but as an index of hepatocyte anabolism, the association between cholesterol and hepatocyte regeneration has not been taken seriously. Based on the association between cholesterol and liver regeneration, this article reviews its significance and potential value in the clinical treatment of liver failure, in order to understand the pathogenesis of liver failure from another perspective and provide new ideas for the diagnosis and treatment of liver failure and the development of drugs.

     

    • FullText(HTML)
  • loading
    • References(55)
  • [1]
    WU J, YIN F, ZHOU X. Efficacy of nucleoside analogues for hepatitis B virus-related liver failure: A network meta-analysis[J]. Acta Pharm, 2018, 68(1): 19-30. DOI: 10.2478/acph-2018-0010.
    [2]
    LEE CW, CHEN YF, WU HH, et al. Historical perspectives and advances in mesenchymal stem cell research for the treatment of liver diseases[J]. Gastroenterology, 2018, 154(1): 46-56. DOI: 10.1053/j.gastro.2017.09.049.
    [3]
    KOK B, KARVELLAS CJ. Management of cerebral edema in acute liver failure[J]. Semin Respir Crit Care Med, 2017, 38(6): 821-829. DOI: 10.1055/s-0037-1608772.
    [4]
    TORRES S, BAULIES A, INSAUSTI-URKIA N, et al. Endoplasmic reticulum stress-induced upregulation of STARD1 promotes acetaminophen-induced acute liver failure[J]. Gastroenterology, 2019, 157(2): 552-568. DOI: 10.1053/j.gastro.2019.04.023.
    [5]
    YAN N, YAN T, XIA Y, et al. The pathophysiological function of non-gastrointestinal farnesoid X receptor[J]. Pharmacol Ther, 2021, 226: 107867. DOI: 10.1016/j.pharmthera.2021.107867.
    [6]
    WILLIAMS CM, HARPER CALDERON J, E H, et al. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function[J]. FASEB J, 2021, 35(2): e21286. DOI: 10.1096/fj.202002203R.
    [7]
    GULFO J, ROTONDO F, ÁVALOS de LEÓN CG, et al. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats[J]. J Hepatol, 2020, 73(5): 1131-1143. DOI: 10.1016/j.jhep.2020.05.007.
    [8]
    BAI Q, ZHANG X, XU L, et al. Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein-1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease[J]. Metabolism, 2012, 61(6): 836-845. DOI: 10.1016/j.metabol.2011.11.014.
    [9]
    CHEN YY, LAN YM, WANG MG, et al. Mechanism of action of bile acid-farnesoid X receptor-intestinal microecological axis in the development of liver failure and liver regeneration[J]. J Clin Hepatol, 2021, 37(2): 480-484. DOI: 10.3969/j.issn.1001-5256.2021.02.049.

    陈研焰, 蓝艳梅, 王明刚, 等. 胆汁酸-法尼醇核受体R-肠道微生态轴在肝衰竭发生及肝再生中的作用机制[J]. 临床肝胆病杂志, 2021, 37(2): 480-484. DOI: 10.3969/j.issn.1001-5256.2021.02.049.
    [10]
    LONG FL, LIN Y, PENG ZM, et al. Research advances in animal models of acute liver failure[J]. J Clin Hepatol, 2021, 37(1): 204-208. DOI: 10.3969/j.issn.1001-5256.2021.01.045.

    龙富立, 林镛, 彭子明, 等. 急性肝衰竭动物模型的研究进展[J]. 临床肝胆病杂志, 2021, 37(1): 204-208. DOI: 10.3969/j.issn.1001-5256.2021.01.045.
    [11]
    van MIERLO KM, SCHAAP FG, DEJONG CH, et al. Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure[J]. J Hepatol, 2016, 65(6): 1217-1231. DOI: 10.1016/j.jhep.2016.06.006.
    [12]
    HASHEMI GORADEL N, DARABI M, SHAMSASENJAN K, et al. Methods of liver stem cell therapy in rodents as models of human liver regeneration in hepatic failure[J]. Adv Pharm Bull, 2015, 5(3): 293-298. DOI: 10.5681/apb.2015.041.
    [13]
    MICHALOPOULOS GK. Hepatostat: Liver regeneration and normal liver tissue maintenance[J]. Hepatology, 2017, 65(4): 1384-1392. DOI: 10.1002/hep.28988.
    [14]
    KHOLODENKO IV, YARYGIN KN. Cellular mechanisms of liver regeneration and cell-based therapies of liver diseases[J]. Biomed Res Int, 2017, 2017: 8910821. DOI: 10.1155/2017/8910821.
    [15]
    ADAMEK B, ZALEWSKA-ZIOB M, STRZELCZYK JK, et al. Hepatocyte growth factor and epidermal growth factor activity during later stages of rat liver regeneration upon interferon α-2b influence[J]. Clin Exp Hepatol, 2017, 3(1): 9-15. DOI: 10.5114/ceh.2017.65499.
    [16]
    MURTHA-LEMEKHOVA A, FUCHS J, GHAMARNEJAD O, et al. Influence of cytokines, circulating markers and growth factors on liver regeneration and post-hepatectomy liver failure: A systematic review and meta-analysis[J]. Sci Rep, 2021, 11(1): 13739. DOI: 10.1038/s41598-021-92888-4.
    [17]
    DOIGNON I, JULIEN B, SERRIÈRE-LANNEAU V, et al. Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis[J]. J Hepatol, 2011, 54(3): 481-488. DOI: 10.1016/j.jhep.2010.07.012.
    [18]
    SOUSA IP Jr, CARVALHO C, GOMES A. Current understanding of the role of cholesterol in the life cycle of alphaviruses[J]. Viruses, 2020, 13(1): 35. DOI: 10.3390/v13010035.
    [19]
    GUZIOR DV, QUINN RA. Review: Microbial transformations of human bile acids[J]. Microbiome, 2021, 9(1): 140. DOI: 10.1186/s40168-021-01101-1.
    [20]
    MATHUR B, SHAJAHAN A, ARIF W, et al. Nuclear receptors FXR and SHP regulate protein N-glycan modifications in the liver[J]. Sci Adv, 2021, 7(17): eabf4865. DOI: 10.1126/sciadv.abf4865.
    [21]
    TRAUNER M, BOYER JL. Bile salt transporters: Molecular characterization, function, and regulation[J]. Physiol Rev, 2003, 83(2): 633-671. DOI: 10.1152/physrev.00027.2002.
    [22]
    HOFMANN AF. The enterohepatic circulation of bile acids in mammals: Form and functions[J]. Front Biosci (Landmark Ed), 2009, 14: 2584-2598. DOI: 10.2741/3399.
    [23]
    PEREZ MJ, BRIZ O. Bile-acid-induced cell injury and protection[J]. World J Gastroenterol, 2009, 15(14): 1677-1689. DOI: 10.3748/wjg.15.1677.
    [24]
    ALVAREZ-SOLA G, URIARTE I, LATASA MU, et al. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(4 Pt B): 1326-1334. DOI: 10.1016/j.bbadis.2017.06.025.
    [25]
    PANZITT K, WAGNER M. FXR in liver physiology: Multiple faces to regulate liver metabolism[J]. Biochim Biophys Acta Mol Basis Dis, 2021, 1867(7): 166133. DOI: 10.1016/j.bbadis.2021.166133.
    [26]
    MEYER K, MORALES-NAVARRETE H, SEIFERT S, et al. Bile canaliculi remodeling activates YAP via the actin cytoskeleton during liver regeneration[J]. Mol Syst Biol, 2020, 16(2): e8985. DOI: 10.15252/msb.20198985.
    [27]
    PENG J, YU J, XU H, et al. Enhanced liver regeneration after partial hepatectomy in sterol regulatory element-binding protein (SREBP)-1c-null mice is associated with increased hepatocellular cholesterol availability[J]. Cell Physiol Biochem, 2018, 47(2): 784-799. DOI: 10.1159/000490030.
    [28]
    DE GIORGI M, JARRETT KE, BURTON JC, et al. Depletion of essential isoprenoids and ER stress induction following acute liver-specific deletion of HMG-CoA reductase[J]. J Lipid Res, 2020, 61(12): 1675-1686. DOI: 10.1194/jlr.RA120001006.
    [29]
    NUÑEZ-GARCIA M, GOMEZ-SANTOS B, SAENZ de URTURI D, et al. Atorvastatin provides a new lipidome improving early regeneration after partial hepatectomy in osteopontin deficient mice[J]. Sci Rep, 2018, 8(1): 14626. DOI: 10.1038/s41598-018-32919-9.
    [30]
    JANG YO, KIM SH, CHO MY, et al. Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis[J]. Biochem Biophys Res Commun, 2018, 497(1): 264-271. DOI: 10.1016/j.bbrc.2018.02.067.
    [31]
    TOKUNAGA T, IKEGAMI T, YOSHIZUMI T, et al. Beneficial effects of fluvastatin on liver microcirculation and regeneration after massive hepatectomy in rats[J]. Dig Dis Sci, 2008, 53(11): 2989-2994. DOI: 10.1007/s10620-008-0241-y.
    [32]
    ZHANG L, HUANG X, MENG Z, et al. Significance and mechanism of CYP7a1 gene regulation during the acute phase of liver regeneration[J]. Mol Endocrinol, 2009, 23(2): 137-145. DOI: 10.1210/me.2008-0198.
    [33]
    IBRAHIM S, DAYOUB R, SABERI V, et al. Augmenter of Liver Regeneration (ALR) regulates bile acid synthesis and attenuates bile acid-induced apoptosis via glycogen synthase kinase-3β (GSK-3β) inhibition[J]. Exp Cell Res, 2020, 397(1): 112343. DOI: 10.1016/j.yexcr.2020.112343.
    [34]
    HAKIM A, MOLL M, BRANCALE J, et al. Genetic variation in the mitochondrial glycerol-3-phosphate acyltransferase is associated with liver injury[J]. Hepatology, 2021, 74(6): 3394-3408. DOI: 10.1002/hep.32038.
    [35]
    ZHANG J, LI J, CHEN Y, et al. Prognostic factors related to the mortality rate of acute-on-chronic liver failure patients[J]. Diabetes Metab Syndr Obes, 2021, 14: 2573-2580. DOI: 10.2147/DMSO.S309641.
    [36]
    DELGADO-COELLO B, BRIONES-ORTA MA, MACíAS-SILVA M, et al. Cholesterol: Recapitulation of its active role during liver regeneration[J]. Liver Int, 2011, 31(9): 1271-1284. DOI: 10.1111/j.1478-3231.2011.02542.x.
    [37]
    DAL K, BULUR O, ATA N, et al. The role of insulin - like growth factor - 1 on steatohepatitis[J]. Acta Gastroenterol Belg, 2017, 80(1): 21-24.
    [38]
    DING BS, LIU CH, SUN Y, et al. HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver[J]. JCI Insight, 2016, 1(21): e87058. DOI: 10.1172/jci.insight.87058.
    [39]
    SYDOR S, GU Y, SCHLATTJAN M, et al. Steatosis does not impair liver regeneration after partial hepatectomy[J]. Lab Invest, 2013, 93(1): 20-30. DOI: 10.1038/labinvest.2012.142.
    [40]
    WANG G, CHEN QM, MINUK GY, et al. Enhanced expression of cytosolic fatty acid binding protein and fatty acid uptake during liver regeneration in rats[J]. Mol Cell Biochem, 2004, 262(1-2): 41-49. DOI: 10.1023/b:mcbi.0000038214.52184.82.
    [41]
    CICOGNANI C, MALAVOLTI M, MORSELLI-LABATE AM, et al. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis[J]. Arch Intern Med, 1997, 157(7): 792-796.
    [42]
    BAUMBERGER C, ULEVITCH RJ, DAYER JM. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein[J]. Pathobiology, 1991, 59(6): 378-383. DOI: 10.1159/000163681.
    [43]
    GALBOIS A, THABUT D, TAZI KA, et al. Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis[J]. Hepatology, 2009, 49(1): 175-184. DOI: 10.1002/hep.22582.
    [44]
    GUO L, AI J, ZHENG Z, et al. High density lipoprotein protects against polymicrobe-induced sepsis in mice[J]. J Biol Chem, 2013, 288(25): 17947-17953. DOI: 10.1074/jbc.M112.442699.
    [45]
    ETOGO-ASSE FE, VINCENT RP, HUGHES SA, et al. High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness[J]. Liver Int, 2012, 32(1): 128-136. DOI: 10.1111/j.1478-3231.2011.02657.x.
    [46]
    MANKA P, OLLIGES V, BECHMANN LP, et al. Low levels of blood lipids are associated with etiology and lethal outcome in acute liver failure[J]. PLoS One, 2014, 9(7): e102351. DOI: 10.1371/journal.pone.0102351.
    [47]
    ŽALOUDKOVÁ L, TICHÁ A, NEKVINDOVÁ J, et al. Different forms of ursolic acid and their effect on liver regeneration[J]. Evid Based Complement Alternat Med, 2020, 2020: 4074068. DOI: 10.1155/2020/4074068.
    [48]
    XU L, KIM JK, BAI Q, et al. 5-cholesten-3β, 25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model[J]. Mol Pharmacol, 2013, 83(3): 648-658. DOI: 10.1124/mol.112.081505.
    [49]
    ZHANG X, BAI Q, XU L, et al. Cytosolic sulfotransferase 2B1b promotes hepatocyte proliferation gene expression in vivo and in vitro[J]. Am J Physiol Gastrointest Liver Physiol, 2012, 303(3): g344-g355. DOI: 10.1152/ajpgi.00403.2011.
    [50]
    XU L, SHEN S, MA Y, et al. 25-Hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARγ signaling in human THP-1 macrophages[J]. Am J Physiol Endocrinol Metab, 2012, 302(7): e788-e799. DOI: 10.1152/ajpendo.00337.2011.
    [51]
    SALADIN R, FAJAS L, DANA S, et al. Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis[J]. Cell Growth Differ, 1999, 10(1): 43-48.
    [52]
    NING Y, KIM JK, MIN HK, et al. Cholesterol metabolites alleviate injured liver function and decrease mortality in an LPS-induced mouse model[J]. Metabolism, 2017, 71: 83-93. DOI: 10.1016/j.metabol.2016.12.007.
    [53]
    INOUE M, SHINOHARA ML. The role of interferon-β in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis-in the perspective of inflammasomes[J]. Immunology, 2013, 139(1): 11-18. DOI: 10.1111/imm.12081.
    [54]
    RUSSELL DW. The enzymes, regulation, and genetics of bile acid synthesis[J]. Annu Rev Biochem, 2003, 72: 137-174. DOI: 10.1146/annurev.biochem.72.121801.161712.
    [55]
    REBOLDI A, DANG EV, MCDONALD JG, et al. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon[J]. Science, 2014, 345(6197): 679-684. DOI: 10.1126/science.1254790.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (804) PDF downloads(61) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return